20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants. A Phase 3, Randomized, Double-Blind, Third Party Unblind Trial to Evaluate the Safety and
Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants.
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06482077
ClinicalTrials.gov Identifier (NCT): NCT04530838
Protocol ID: B7471016
PrintDownloadOpen Plain Language Summary Result: Click here